Browne Jacobson appointed to three major health panels

Health law firm Browne Jacobson has been appointed to three key health panels by the National Health Service Litigation Authority (NHS LA) following a highly competitive tendering process.

The firm has been re-appointed to the NHS LA’s clinical and non-clinical liability legal panels. The team has also been appointed to a new specialist healthcare panel which will provide advice on a range of matters including inquests, corporate advice, and judicial review to many arms length bodies under the Department of Health umbrella including the Care Quality Commission, Monitor, National Institute for Health and Clinical Excellence and Health Research Authority.

A total of fourteen law firms have been appointed to serve across the three panels. The four year appointment took effect as of 28 May 2013.

According to independent legal directory, Chambers, Browne Jacobson has one of the leading health law teams in the country. Its 80+ strong team of specialist healthcare lawyers act for a broad range of public and independent healthcare organisations. In addition to the NHS LA the firm is also a legal panel adviser to the Medical Protection Society as well as a member of most of the large health sector procurement panels including the Health Trust Europe panel, London Procurement Partnership, the NHS Commercial Alliance panel (Eastern and South Eastern regions), North West Collaborative Procurement Hub and the CPC Hub (Yorkshire and Humberside)

Nick Parsons, the lead NHS LA partner at Browne Jacobson, said:

“We are delighted to be appointed to all three panels and be given the opportunity to continue our long standing relationship with the NHS LA.

“We are only one of five firms appointed to all three panels and see this as an endorsement of our healthcare teams and the quality of the work they deliver to the NHS.

Established in 1995, the NHS Litigation Authority is a Special Health Authority dealing with clinical and non-clinical claims made against the NHS in England.